ONLY $9.90 DELIVERY INFO

Close Notification

Your cart does not contain any items

$167.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Churchill Livingstone
28 August 2025
In this issue of Cardiology Clinics, guest editors Drs. Silvi Shah and Janani Rangaswami bring their considerable expertise to the topic of Cardio-Kidney-Metabolic Disorder. Top experts discuss key topics such as definition, staging, risk assessment, and therapeutic considerations; sex difference in CVD with kidney disease; obesity and CKM health: ethnicity-based risk and clinical considerations; SGLT2i across the spectrum of CKM health; and more.

Contains 12 relevant, practice-oriented topics including atherosclerotic cardiovascular disease in CKM syndrome; kidney transplant and CKM health; pregnancy and CKM Health; nutrition and CKM health; CKM health in pediatrics and primordial prevention; and more Provides in-depth clinical reviews on cardio-kidney-metabolic disorder, offering actionable insights for clinical practice Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Edited by:   , , , , ,
Imprint:   Churchill Livingstone
Country of Publication:   United Kingdom
Dimensions:   Height: 254mm,  Width: 178mm, 
Weight:   450g
ISBN:   9780443345630
ISBN 10:   0443345635
Series:   The Clinics: Internal Medicine
Pages:   240
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease Sex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney Disease Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/ Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions Atherosclerotic Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome Kidney Transplant and Cardiovascular-Kidney-Metabolic Health Long-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsia A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease

See Also